-
-
-
-
-
-
-
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
-
-
-
-
-
-
-
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) to Acquire POINT Biopharma (PNT) for $12.50/sh Cash or $1.4B
-
-
-
-
-
-
-
Emerson Completes Pentair Valves & Controls Acquisition
-
-
-
-
-
-
-
CPI Card Group Appoints Jason Bohrer as Senior Vice President, Operations
-
-
-
-
-
-
1,154,856 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

